Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
97.905,74
-0,20%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Exelixis Inc (EXEL) Exelixis Inc (EXEL) Notizie

Exelixis Inc

EXEL
33,97
0,03 (0,09%)
03 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/12/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202419:12EDGAR2Form 144 - Report of proposed sale of securities
27/11/202422:05BWExelixis to Webcast Fireside Chats as Part of Investor..
27/11/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:05BWExelixis Provides Regulatory Update Related to Supplemental..
22/11/202422:01EDGAR2Form 144 - Report of proposed sale of securities
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202400:50EDGAR2Form 144 - Report of proposed sale of securities
18/11/202422:10EDGAR2Form 144 - Report of proposed sale of securities
08/11/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:05BWExelixis to Webcast Fireside Chats as Part of Investor..
06/11/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
01/11/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202421:54EDGAR2Form 144 - Report of proposed sale of securities
01/11/202421:47EDGAR2Form 144 - Report of proposed sale of securities
30/10/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:10EDGAR2Form 144 - Report of proposed sale of securities
29/10/202421:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:07EDGAR2Form 8-K - Current report
29/10/202421:05BWExelixis Announces Third Quarter 2024 Financial Results and..
15/10/202422:15EDGAR2Form 8-K - Current report
15/10/202422:05BWExelixis to Release Third Quarter 2024 Financial Results on..
15/10/202419:57BWExelixis Announces Update on Second Patent Litigation Trial..
15/10/202414:00EDGAR2Form 8-K - Current report
14/10/202414:00BWExelixis and Merck Sign Clinical Development Collaboration..
09/10/202414:30PRNCAONCOLOGY COMMERCIALIZATION LEADER P.J. HALEY TO JOIN..
04/10/202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202422:24EDGAR2Form 144 - Report of proposed sale of securities
16/9/202414:45BWExelixis Announces Final Results from Phase 3 Pivotal..
15/9/202414:45BWExelixis Presents Final Overall Survival Results from Phase..
29/8/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:05BWExelixis to Webcast Fireside Chats as Part of Investor..
17/8/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202423:01EDGAR2Form 144 - Report of proposed sale of securities
13/8/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 33,79 Min: 33,79 Max: 34,12
Chiusura: 33,94

La tua Cronologia

NASDAQ
EXEL
Exelixis
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network